Compare ECVT & ASTH Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.
Current Price
Current Price
| Metric | ECVT | ASTH |
|---|---|---|
| Founded | 1935 | 1994 |
| Country | United States | United States |
| Employees | N/A | N/A |
| Industry | Major Chemicals | Professional Services |
| Sector | Industrials | Consumer Discretionary |
| Exchange | Nasdaq | Nasdaq |
| Market Cap | 1.6B | 1.9B |
| IPO Year | 2017 | 2015 |
| Metric | ECVT | ASTH |
|---|---|---|
| Price | $12.97 | $38.38 |
| Analyst Decision | Strong Buy | Strong Buy |
| Analyst Count | 5 | 7 |
| Target Price | $14.00 | ★ $34.86 |
| AVG Volume (30 Days) | ★ 1.7M | 441.4K |
| Earning Date | 05-05-2026 | 05-07-2026 |
| Dividend Yield | N/A | N/A |
| EPS Growth | N/A | ★ N/A |
| EPS | 0.04 | ★ 0.29 |
| Revenue | ★ $723,515,000.00 | $519,907,752.00 |
| Revenue This Year | $29.07 | $27.38 |
| Revenue Next Year | $6.71 | $10.78 |
| P/E Ratio | $327.25 | ★ $133.17 |
| Revenue Growth | 2.70 | ★ 45.90 |
| 52 Week Low | $7.39 | $18.08 |
| 52 Week High | $15.09 | $40.13 |
| Indicator | ECVT | ASTH |
|---|---|---|
| Relative Strength Index (RSI) | 43.04 | 53.33 |
| Support Level | $12.74 | $36.95 |
| Resistance Level | $15.01 | $39.93 |
| Average True Range (ATR) | 0.33 | 1.45 |
| MACD | -0.03 | -0.21 |
| Stochastic Oscillator | 34.04 | 45.83 |
Ecovyst Inc is an integrated and provider of materials, specialty catalysts and services. Its products contribute to lower emissions and cleaner air, higher fuel efficiency and cleaner fuels, and key enablers to advance transition to clean energy. The company has one operating segment. The Company's single reportable segment, Ecoservices, derives its revenue through the sale of virgin and regenerated sulfuric acid products and services.
Astrana Health Inc is a patient-centered, physician-centric integrated population health management company. The company is working to provide coordinated, outcomes-based medical care cost-effectively. It is focused on physicians providing high-quality medical care, population health management, and care coordination for patients, particularly senior patients and patients with multiple chronic conditions. The company's three reportable segments are Care Partners, Care Delivery, and Care Enablement. It generates the majority of its revenue from the Care Partners segment.